An overview of traditional Chinese medicine affecting gut microbiota in obesity

Front Endocrinol (Lausanne). 2023 Mar 1:14:1149751. doi: 10.3389/fendo.2023.1149751. eCollection 2023.

Abstract

Obesity, a chronic metabolic disease with a complex pathophysiology, is caused by several variables. High-fat diets lead to the disruption of the gut microbiota and impaired gut barrier function in obese people. The dysbiosis and its metabolites through the intestinal barrier lead to an imbalance in energy metabolism and inflammatory response, which eventually contributes to the development of chronic diseases such as diabetes, hypertension, and cardiovascular disease. Current medicines are therapeutic to obesity in the short term; however, they may bring significant physical and emotional problems to patients as major side effects. Therefore, it is urgent to explore new therapeutic methods that have definite efficacy, can be taken for a long time, and have mild adverse effects. Numerous studies have demonstrated that traditional Chinese medicine (TCM) can control the gut microbiota in a multi-targeted and comprehensive manner, thereby restoring flora homeostasis, repairing damaged intestinal mucosal barriers, and eventually curbing the development of obesity. The active ingredients and compounds of TCM can restore the normal physiological function of the intestinal mucosal barrier by regulating gut microbiota to regulate energy metabolism, inhibit fat accumulation, affect food appetite, and reduce intestinal mucosal inflammatory response, thereby effectively promoting weight loss and providing new strategies for obesity prevention and treatment. Although there are some studies on the regulation of gut microbiota by TCM to prevent and treat obesity, all of them have the disadvantage of being systematic and comprehensive. Therefore, this work comprehensively describes the molecular mechanism of obesity mediated by gut microbiota based on the research state of obesity, gut microbiota, and TCM. A comprehensive and systematic summary of TCM targeting the regulation of gut microbiota for the treatment of obesity should be conducted in order to provide new strategies and ideas for the treatment of obesity.

Keywords: active ingredients; gut microbiota; obesity; short-chain fatty acids (SCFAs); traditional Chinese medicine.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drugs, Chinese Herbal* / pharmacology
  • Drugs, Chinese Herbal* / therapeutic use
  • Gastrointestinal Microbiome*
  • Humans
  • Medicine, Chinese Traditional
  • Obesity / drug therapy
  • Weight Loss

Substances

  • Drugs, Chinese Herbal

Grants and funding

This study was supported by the Heilongjiang Province in Special Funding for Postdoctoral (LBH-Q20185), the Heilongjiang Provincial North Medicine and Function Food for Featured Discipline of Heilongjiang Province (2018-TSXK-02), the Technological Innovation Team Construction Project of Heilongjiang Provincial Department of Education (2021-KYYEF-0638), the Key Program of the Natural Science Foundation of Heilongjiang Province of China (ZD2022H006), the Joint Guidance Project of the Natural Science Foundation of Heilongjiang Province (LH2022H093), and the Basic Research Project of Fundamental Research Business Expenses of Education Department in Heilongjiang Province (No. 2022-KYYWF-0615).